DOX CAS No.25316-40-9 / Cat No.EBD41439
DOX
doxorubicinhydrochloride
adriamycin
(8S,10S)-10-[(3-amino-2,3,6-trideoxy-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-naphthacene-5,12-dionehydrochloride
Doxorubicin,HCl
(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dionehydrochloride
(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl3-amino-2,3,6-trideoxyhexopyranosidehydrochloride(1:1)
(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosidehydrochloride(1:1)
DoxorubicinHCL
DoxourbicinHCl
(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,
Properties
-
Appearance:
orange-red crystalline solid
-
Melting point:
216 °C (dec.)(lit.)
-
Boiling point:
810.3 °C at 760 mmHg
-
Flashing point:
443.8 °C
-
Storage temperature:
2-8°C
-
Solubility:
H2O: 10 mg/mL, clear, red-orange
Safety Information
-
Symbol:
-
Signal words:
Danger -
Hazard statements:
H302 Harmful if swallowed.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H350 May cause cancer.
-
Precautionary statements:
P201 Obtain special instructions before use.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P308+P313 IF exposed or concerned: Get medical advice/attention.
NMR Spectrum
1H NMR
13C NMR
